Emerging Drugs and Targets for Parkinson's Disease (Hardcover)

Jose Gonzalez-Castano

ISBN 10: 1849736170 / ISBN 13: 9781849736176
Usado / Hardcover / Cantidad: 0
Disponible en otras librerías
Ver todos  los ejemplares de este libro

Sobre el libro

Lamentablemente este ejemplar en específico ya no está disponible. A continuación, le mostramos una lista de copias similares.

Descripción:

Hardcover. This exemplary new book reviews some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets under the validation process to try .Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. 402 pages. 0.762. N° de ref. de la librería

Sobre este título:

Valoración del libro brindada por Goodreads:
0 valoración promedio
(0 valoraciones)

Sinopsis:

Affecting over 1.5 million people across the world, Parkinson's disease is a progressive neurological condition characterized, in part, by the loss of dopaminergic neurons in the substantia nigra pars compacta. It affects 1.5% of the global population over 65 years of age. As life expectancy is increasing, over the next few years the number of patients with Parkinson´s disease will grow exponentially. To date, there are no available treatments that are capable of curing Parkinson´s disease, and the current goal of therapy, dopamine replacement strategies, is to reduce symptoms. After several years of disease progression, treatment is complicated by the onset of motor fluctuations and dyskinesias. This information reveals the great importance and social need of finding an effective therapeutic intervention for Parkinson´s disease.


This exemplary new book reviews some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets currently undergoing the validation process to try to reach the Parkinson´s drug market in the next few years as potential disease modifying drugs. Providing up to date and comprehensive coverage, this book is essential reading for researchers working in academia and industry in any aspect of medicinal chemistry or drug discovery.

Book Description: This exemplary new book reviews some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets under the validation process that will reach the Parkinson's drug market over the next few years as disease modifying drugs. The contents are divided into four main sections that will cover: L-Dopa and dopaminergic agents; Alpha synuclein hypothesis; neuroprotective therapies and neuroregenerative strategies. A key feature of the title is that it presents contributions from a number of opinion leaders from both industry and academia. The book is essential reading for medicinal chemists, chemical biologists, and pharmaceutical scientists

"Sobre este título" puede pertenecer a otra edición de este libro.

Detalles bibliográficos

Título: Emerging Drugs and Targets for Parkinson's ...
Año de publicación: 2013
Encuadernación: Hardcover
Condición del libro: New

Los mejores resultados en AbeBooks

1.

Ana Martinez, Carmen Gil, Ana Martinez, Jose Gonzalez Castano, Jose Lopez-Barneo
Editorial: Royal Society of Chemistry
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Tapa dura Cantidad: 1
Librería
THE SAINT BOOKSTORE
(Southport, Reino Unido)
Valoración
[?]

Descripción Royal Society of Chemistry. Hardback. Estado de conservación: new. BRAND NEW, Emerging Drugs and Targets for Parkinson's Disease, Ana Martinez, Carmen Gil, Ana Martinez, Jose Gonzalez Castano, Jose Lopez-Barneo, Affecting over 1.5 million people across the world, Parkinson's disease is a progressive neurological condition characterized, in part, by the loss of dopaminergic neurons in the substantia nigra pars compacta. It affects 1.5% of the global population over 65 years of age. As life expectancy is increasing, over the next few years the number of patients with Parkinson's disease will grow exponentially. To date, there are no available treatments that are capable of curing Parkinson's disease, and the current goal of therapy, dopamine replacement strategies, is to reduce symptoms. After several years of disease progression, treatment is complicated by the onset of motor fluctuations and dyskinesias. This information reveals the great importance and social need of finding an effective therapeutic intervention for Parkinson's disease. This exemplary new book reviews some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets currently undergoing the validation process to try to reach the Parkinson's drug market in the next few years as potential disease modifying drugs. Providing up to date and comprehensive coverage, this book is essential reading for researchers working in academia and industry in any aspect of medicinal chemistry or drug discovery. Nº de ref. de la librería B9781849736176

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 163,23
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 7,78
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

2.

Editorial: Royal Society Of Chemistry, United Kingdom (2013)
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Tapa dura Cantidad: 10
Librería
The Book Depository
(London, Reino Unido)
Valoración
[?]

Descripción Royal Society Of Chemistry, United Kingdom, 2013. Hardback. Estado de conservación: New. Language: English . Brand New Book. Affecting over 1.5 million people across the world, Parkinson s disease is a progressive neurological condition characterized, in part, by the loss of dopaminergic neurons in the substantia nigra pars compacta. It affects 1.5 of the global population over 65 years of age. As life expectancy is increasing, over the next few years the number of patients with Parkinson s disease will grow exponentially. To date, there are no available treatments that are capable of curing Parkinson s disease, and the current goal of therapy, dopamine replacement strategies, is to reduce symptoms. After several years of disease progression, treatment is complicated by the onset of motor fluctuations and dyskinesias. This information reveals the great importance and social need of finding an effective therapeutic intervention for Parkinson s disease. This exemplary new book reviews some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets currently undergoing the validation process to try to reach the Parkinson s drug market in the next few years as potential disease modifying drugs. Providing up to date and comprehensive coverage, this book is essential reading for researchers working in academia and industry in any aspect of medicinal chemistry or drug discovery. Nº de ref. de la librería AAC9781849736176

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 173,07
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

3.

Editorial: Royal Society Of Chemistry, United Kingdom (2013)
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Tapa dura Cantidad: 10
Librería
The Book Depository US
(London, Reino Unido)
Valoración
[?]

Descripción Royal Society Of Chemistry, United Kingdom, 2013. Hardback. Estado de conservación: New. Language: English . Brand New Book. Affecting over 1.5 million people across the world, Parkinson s disease is a progressive neurological condition characterized, in part, by the loss of dopaminergic neurons in the substantia nigra pars compacta. It affects 1.5 of the global population over 65 years of age. As life expectancy is increasing, over the next few years the number of patients with Parkinson s disease will grow exponentially. To date, there are no available treatments that are capable of curing Parkinson s disease, and the current goal of therapy, dopamine replacement strategies, is to reduce symptoms. After several years of disease progression, treatment is complicated by the onset of motor fluctuations and dyskinesias. This information reveals the great importance and social need of finding an effective therapeutic intervention for Parkinson s disease. This exemplary new book reviews some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets currently undergoing the validation process to try to reach the Parkinson s drug market in the next few years as potential disease modifying drugs. Providing up to date and comprehensive coverage, this book is essential reading for researchers working in academia and industry in any aspect of medicinal chemistry or drug discovery. Nº de ref. de la librería AAC9781849736176

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 175,57
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

4.

Gonzalez Castano Jose,Lopez-Barneo Jose,Martinez Martin,Pablo,Ana,Gil,Carmen
Editorial: The Royal Society of Chemistry 2013-07-30 (2013)
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Cantidad: 5
Librería
Chiron Media
(Wallingford, Reino Unido)
Valoración
[?]

Descripción The Royal Society of Chemistry 2013-07-30, 2013. Estado de conservación: New. Brand new book, sourced directly from publisher. Dispatch time is 24-48 hours from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Nº de ref. de la librería NU-MAR-00048611

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 176,83
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,35
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Ana Martinez
Editorial: Royal Society of Chemistry (2013)
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Cantidad: > 20
Librería
Books2Anywhere
(Fairford, GLOS, Reino Unido)
Valoración
[?]

Descripción Royal Society of Chemistry, 2013. HRD. Estado de conservación: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Nº de ref. de la librería CA-9781849736176

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 177,50
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 10,09
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

6.

Jose Gonzalez-Castano, Jose Gonzalez-Castano
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Cantidad: 5
Librería
GreatBookPrices
(Columbia, MD, Estados Unidos de America)
Valoración
[?]

Descripción Estado de conservación: New. Nº de ref. de la librería 20014734-n

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 180,34
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 2,24
A Estados Unidos de America
Destinos, gastos y plazos de envío

7.

Editorial: Royal Society of Chemistry
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Cantidad: 3
Librería
Majestic Books
(London, ,, Reino Unido)
Valoración
[?]

Descripción Royal Society of Chemistry. Estado de conservación: New. pp. 408. Nº de ref. de la librería 53991768

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 207,34
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,17
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

8.

Editorial: Royal Society of Chemistry (2013)
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Tapa dura Cantidad: 2
Librería
Murray Media
(North Miami Beach, FL, Estados Unidos de America)
Valoración
[?]

Descripción Royal Society of Chemistry, 2013. Hardcover. Estado de conservación: New. Never used!. Nº de ref. de la librería P111849736170

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 213,27
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 1,69
A Estados Unidos de America
Destinos, gastos y plazos de envío

9.

Editorial: Royal Soc Chem (2013)
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Tapa dura Cantidad: 2
Librería
Revaluation Books
(Exeter, Reino Unido)
Valoración
[?]

Descripción Royal Soc Chem, 2013. Hardcover. Estado de conservación: Brand New. 408 pages. 9.69x6.54x1.26 inches. In Stock. Nº de ref. de la librería x-1849736170

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 212,62
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,72
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

10.

Editorial: Royal Society of Chemistry (2013)
ISBN 10: 1849736170 ISBN 13: 9781849736176
Nuevos Tapa dura Cantidad: 1
Librería
Irish Booksellers
(Rumford, ME, Estados Unidos de America)
Valoración
[?]

Descripción Royal Society of Chemistry, 2013. Hardcover. Estado de conservación: New. book. Nº de ref. de la librería M1849736170

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 247,71
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

Existen otras 4 copia(s) de este libro

Ver todos los resultados de su búsqueda